Đang chuẩn bị liên kết để tải về tài liệu:
A diagnostic marker for superficial urothelial bladder carcinoma: Lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Pathological stage and grade have limited ability to predict the outcomes of superficial urothelial bladder carcinoma at initial transurethral resection (TUR). AT-motif binding factor 1 (ATBF1) is a tumor suppressive transcription factor that is normally localized to the nucleus but has been detected in the cytoplasm in several cancers. |

TÀI LIỆU LIÊN QUAN

An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker

A diagnostic marker for superficial urothelial bladder carcinoma: Lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggests malignant progression

Circular RNA CCT3 is a unique molecular marker in bladder cancer

Proex C as diagnostic marker for detection of urothelial carcinoma in urinary samples: A review

Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: A retrospective cohort study

Identification of genomic regions and diagnostic markers for resistance to aflatoxin contamination in peanut (Arachis hypogaea L.)

Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer

Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma

Diagnostic value of ascitic fluid lactoferrin, calprotectin, and calprotectin to albumin ratio in spontaneous bacterial peritonitis

Serum CD26 levels in patients with gastric cancer: A novel potential diagnostic marker